A Single-center, single-blind, randomized, parallel-group trial comparing Olanexidine Gluconate with Povidone Iodine during Inguinal Hernioplasty.
- Conditions
- Inguinal hernia
- Registration Number
- JPRN-UMIN000040892
- Lead Sponsor
- Hiroshima City Funairi Citizens Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 660
Not provided
1. Patients with severe ischemic heart disease (NYHA class III or higher). 2. Patients with liver cirrhosis or active hepatitis (liver damage C). 3. Patients with respiratory distress who need oxygen administration due to interstitial pneumonia or pulmonary fibrosis. 4. Patients undergoing dialysis due to chronic renal failure. 5. Patients with active cancer who are thought to affect adverse events. 6. Patients with allergies to beta-lactam antibiotics. 7. Patients who are allergic to olanexidine gluconate or povidone iodine. 8. Patients infected with planned skin incision. 9. Patients with psychosis or psychiatric symptoms who are considered difficult to participate in this study. 10. Patients who did not obtain consent to participate in this study. 11. Patients who are deemed inappropriate for conducting this study by the investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of surgical site infection within 90 days after surgery
- Secondary Outcome Measures
Name Time Method 1. Postoperative hospital stay 2. Outpatient revisit rate 3. Readmission rate 4. The incidence of postoperative hematoma 5. The incidence of surgical treatment for wounds 6. The incidence of all complications 7. Operative mortality